BEIJING – China has newly underway COVID-19 vaccines in Phase III clinical trials in some foreign countries, a spokesman for the Ministry of Foreign Affairs said Wednesday.
Spokesman Zhao Lijian said at a press conference that since the COVID-19 outbreak, the Chinese government has followed five technological approaches to expanding COVID-19 vaccines, namely inactivated vaccines, recombinant protein vaccines, adenovirus-carrying vaccines, influenza attenuated virus vaccines as vectors. . and nucleic acid vaccines. He said China was conducting studies and progression in an orderly manner.
He said China has recently had five COVID-19 vaccines that are recently found in Phase III clinical trials in the United Arab Emirates, Brazil, Pakistan and Peru, like some other vaccines lately in Phase I and II clinical trials.
China has actively conducted foreign cooperation on vaccines through multilateral and bilateral channels and has maintained close communication and cooperation with foreign organizations such as the World Health Organization (WHO), the Global Alliance for Vaccines and Immunization and the Coalition for Innovations in Epidemic Preparedness, Zhao told me. .
He said China had participated in the WHO-sponsored COVID-19 Tool Accelerator Initiative (ACT) and joined the COVAX facility to announce the equitable distribution of vaccines and vaccines are delivered to emerging countries.
Zhao said China expects its vaccines, after the final touch of studies and development, to be included in the COVAX shopping list at a forthcoming date, to contribute to the accessibility and affordability of vaccines in emerging countries.